Lara Valeska Maul Selected Research

Urticaria (Hives)

1/2021

Canakinumab Lacks Efficacy in Treating Adult Patients with Moderate to Severe Chronic Spontaneous Urticaria in a Phase II Randomized Double-Blind Placebo-Controlled Single-Center Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lara Valeska Maul Research Topics

Disease

6	Melanoma (Melanoma, Malignant) 12/2023 - 11/2016
3	Neoplasms (Cancer) 05/2023 - 01/2023
2	Skin Neoplasms (Skin Cancer) 02/2024 - 05/2023
2	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2023 - 06/2022
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 05/2023
1	Nevus (Nevi) 01/2023
1	Vitiligo 09/2022
1	Necrosis 06/2022
1	Premature Birth (Birth, Premature) 06/2022
1	Uveal melanoma 06/2021
1	Cryopyrin-Associated Periodic Syndromes 01/2021
1	Chronic Urticaria 01/2021
1	Fever (Fevers) 01/2021
1	Urticaria (Hives) 01/2021
1	Vasculitis (Vasculitides) 01/2021
1	Exanthema (Rash) 09/2018
1	Renal Insufficiency (Renal Failure) 12/2016
1	Basal Cell Carcinoma (Rodent Ulcer) 12/2016

Drug/Important Bio-Agent (IBA)

2	tributyl phosphate (TBP)IBA 02/2024 - 01/2023
2	AntibodiesIBA 05/2023 - 06/2022
1	Sunscreening Agents (Sunscreens)IBA 12/2023
1	NivolumabIBA 05/2023
1	pembrolizumabIBA 05/2023
1	liquid crystal polymerIBA 01/2023
1	cyclopropapyrroloindoleIBA 09/2022
1	Certolizumab Pegol FDA Link 06/2022
1	Monoclonal AntibodiesIBA 06/2022
1	Interleukin-17 (Interleukin 17)IBA 06/2022
1	Estrogens (Estrogen)FDA Link 06/2022
1	canakinumab FDA Link 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Histamine Antagonists (Antihistamines)IBA 01/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	Interleukin-1 (Interleukin 1)IBA 01/2021
1	Ephedrine FDA LinkGeneric 09/2018
1	HhAntag691IBA 12/2016
1	InterferonsIBA 11/2016
1	Interferon alpha-2 (Roferon-A)FDA Link 11/2016

Therapy/Procedure

7	Therapeutics 12/2023 - 11/2016
2	Immunotherapy 01/2023 - 09/2022
1	Aftercare (After-Treatment) 06/2021